CAS 1648796-29-5

Gimsilumab

CAS: 1648796-29-5

Gimsilumab (MORAb-022) is an anti-c-Fms humanized monoclonal antibody for the study of inflammation and hypoxemia caused by COVID-19.

Purity: 99.49% (SEC-HPLC) - 99.49% (SEC-HPLC)

Color and Shape: Transparent Liquid

Molecular weight: 145.8 kDa (Predicted)

Ref: TM-T77025

Gimsilumab

CAS: 1648796-29-5

Purity: 95%

Molecular weight: G/Mol

Ref: IN-DA02EOBS